WILLIAM DECKER to Imatinib Mesylate
This is a "connection" page, showing publications WILLIAM DECKER has written about Imatinib Mesylate.
Connection Strength
0.016
-
A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts. Bone Marrow Transplant. 2006 Mar; 37(6):575-82.
Score: 0.016
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.